Article citationsMore>>

Wohl, D.A., Yazdanpanah, Y., et al. (2019) Bictegravir Combined with Emtricitabine and Tenofovir Alafenamide versus Dolutegravir, Abacavir, and Lamivudine for Intial Treatment of HIV-1 Infection: Week 96 Results from a Ramdomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial. The Lancet HIV, 6, E355-E363.
https://doi.org/10.1016/S2352-3018(19)30077-3

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top